Research shows SpyGlass, an advanced camera-based treatment, works better than X-ray-guided methods for appendicitis without surgery. In a 2026 study of 153 patients, SpyGlass achieved higher treatment success rates, faster recovery, and only 12% recurrence within 12 months compared to higher rates with X-ray treatment. Both methods are safe alternatives to surgery, but SpyGlass provides superior long-term results.
Researchers compared two minimally invasive methods for treating appendicitis, a painful inflammation of the appendix. According to Gram Research analysis, 153 patients received either SpyGlass (an advanced camera system) or X-ray-guided treatment. The SpyGlass method worked better, had fewer repeat problems after a year, and got patients eating again faster. Both methods were safe and avoided surgery, but SpyGlass showed better long-term results. This research suggests doctors now have an effective non-surgical option for appendix problems that works better than older X-ray methods.
Key Statistics
A 2026 study of 153 patients with appendicitis found that SpyGlass-guided treatment achieved significantly higher success rates and lower 12-month recurrence compared to X-ray-assisted endoscopic retrograde appendicitis therapy (ERAT).
Research from 153 patients treated between June 2022 and July 2024 showed that SpyGlass treatment allowed patients to resume eating faster and required shorter procedure times than X-ray-assisted methods for appendicitis.
According to a 2026 analysis of 153 appendicitis patients, migrated abdominal pain and appendicoliths (small stones in the appendix) were identified as independent risk factors for treatment recurrence within 12 months.
A 2026 study comparing 153 patients found that both SpyGlass and X-ray-assisted endoscopic appendicitis treatment are safe, with rare complications in both groups, making them viable non-surgical alternatives to traditional surgery.
The Quick Take
- What they studied: Whether a newer camera-based method (SpyGlass) works better than X-ray-guided treatment for fixing inflamed appendixes without surgery
- Who participated: 153 patients with appendix inflammation treated at a hospital in China between June 2022 and July 2024. Patients had acute (sudden), subacute (medium-term), or chronic (long-lasting) appendix problems.
- Key finding: SpyGlass treatment succeeded in more patients, patients recovered faster and could eat sooner, and only 12% had problems return within a year compared to higher rates with X-ray methods
- What it means for you: If you develop appendicitis, doctors may now offer you a camera-based treatment that avoids surgery and works better than older methods. However, this treatment may cost more upfront, though it could save money long-term by preventing repeat problems.
The Research Details
Researchers looked back at medical records from 153 patients who received treatment for appendix inflammation between June 2022 and July 2024. They divided patients into two groups based on which treatment method they received: SpyGlass (an advanced camera system) or X-ray-assisted treatment. Both methods use a thin tube inserted through the mouth and digestive system to reach and treat the appendix without cutting open the belly.
The researchers measured many outcomes including whether treatment worked, how long the procedure took, pain levels before and after, how long patients stayed in the hospital, when they could eat again, total costs, any complications, and whether problems came back within 12 months. They used statistical analysis to find patterns and determine which factors predicted success or failure.
This study design is important because it compares two real-world treatments used in actual hospital settings with real patients. By looking at detailed medical records, researchers could measure many important outcomes beyond just whether treatment worked. This helps doctors understand not just effectiveness but also practical concerns like recovery time, cost, and long-term success.
This study has some strengths and limitations. The groups were similar at the start, which is good. However, this was a retrospective study, meaning researchers looked backward at existing records rather than randomly assigning patients to treatments, which is less definitive. The sample size of 153 patients is moderate. The study was conducted at one hospital in China, so results may not apply everywhere. The 12-month follow-up period is good for tracking long-term outcomes.
What the Results Show
SpyGlass treatment succeeded in significantly more patients compared to X-ray-assisted treatment. The SpyGlass procedure took less time to complete, and patients could resume eating sooner after SpyGlass treatment. Pain reduction at 6 hours after the procedure was similar between both groups, showing both methods control pain effectively.
The most important difference appeared in the 12-month follow-up period. Patients treated with SpyGlass had much lower rates of appendix problems returning compared to the X-ray group. This suggests SpyGlass provides more lasting relief. Hospital stay length was similar between groups, meaning both methods got patients home at similar speeds.
The X-ray group had lower total hospitalization costs, which is important for patients concerned about expenses. However, when considering the higher recurrence rates in the X-ray group, patients might need additional treatment later, potentially offsetting the initial cost savings.
Statistical analysis identified two factors that predicted whether problems would return: migrated abdominal pain (pain that moves around the belly) and appendicoliths (small stones in the appendix). Interestingly, no single factor predicted whether the initial treatment would succeed, suggesting both methods work reliably when properly performed. Complications were rare in both groups, confirming both approaches are safe.
This research builds on earlier studies showing that minimally invasive endoscopic treatment works for appendicitis. Previous research established that avoiding surgery is possible and safe. This study advances the field by showing that newer camera technology (SpyGlass) outperforms older X-ray-guided methods. The finding that long-term recurrence is lower with SpyGlass is particularly important because it suggests the newer method provides more complete treatment.
This study looked backward at existing medical records rather than randomly assigning patients to treatments, which can introduce bias. The study was conducted at one hospital in China, so results may not apply to all populations or healthcare systems. The researchers did not report how many patients were approached or declined treatment, so we do not know if the final group represents typical patients. Some patients may have received different follow-up care after treatment, which could affect recurrence rates. The study did not compare costs across different healthcare systems, so cost conclusions may not apply everywhere.
The Bottom Line
For patients with appendicitis, SpyGlass-guided treatment appears to be the better choice if available, as it has higher success rates and lower long-term recurrence. However, X-ray-assisted treatment remains a safe and effective option, particularly for patients with cost concerns. Both methods should be considered minimally invasive alternatives to surgery. Patients with appendicoliths or migrated pain should be monitored closely for recurrence regardless of treatment method. These recommendations are based on moderate-quality evidence from one hospital study.
Patients diagnosed with acute, subacute, or chronic appendicitis should know about these non-surgical options. Doctors performing endoscopic appendix treatment should consider SpyGlass technology for better outcomes. Healthcare administrators should consider the long-term cost benefits of SpyGlass despite higher upfront costs. Patients who cannot tolerate surgery or prefer minimally invasive approaches are ideal candidates. This research may not apply to patients with severe complications or those in healthcare systems without access to these technologies.
Treatment itself takes less than an hour with SpyGlass. Pain relief occurs within hours. Patients can resume eating within 1 to 2 days. Full recovery typically occurs within 1 to 2 weeks. The benefit of lower recurrence rates becomes apparent over 12 months of follow-up. Some patients may experience immediate relief, while others may need several days to feel completely normal.
Frequently Asked Questions
What is SpyGlass and how does it treat appendicitis without surgery?
SpyGlass is an advanced camera system inserted through your mouth and digestive system to reach your appendix. Doctors use the camera to see inside and treat the inflamed appendix directly, avoiding the need to cut open your belly. A 2026 study of 153 patients showed this method works better than older X-ray methods.
How long does it take to recover from SpyGlass appendicitis treatment?
Most patients resume eating within 1 to 2 days and return to normal activities within 1 to 2 weeks. Research from 153 patients showed SpyGlass treatment allowed faster eating recovery compared to X-ray methods, though hospital stay length was similar between both approaches.
What is the recurrence rate for appendicitis after SpyGlass treatment?
A 2026 study of 153 patients found that SpyGlass treatment had significantly lower 12-month recurrence rates compared to X-ray-assisted treatment. Patients with appendicoliths or migrated abdominal pain face higher recurrence risk regardless of treatment method.
Is SpyGlass treatment safer than traditional appendix surgery?
Both SpyGlass and X-ray-assisted endoscopic treatment are minimally invasive and safe, with rare complications in a 2026 study of 153 patients. These methods avoid the risks of traditional surgery like infection and longer recovery, making them safer alternatives for most patients.
How much does SpyGlass appendicitis treatment cost compared to X-ray methods?
X-ray-assisted treatment has lower upfront hospitalization costs. However, SpyGlass has lower recurrence rates, meaning fewer patients need repeat treatment. A 2026 study of 153 patients suggests SpyGlass may save money long-term despite higher initial costs.
Want to Apply This Research?
- Track daily pain levels on a 0-10 scale for the first 2 weeks after treatment, then weekly for 3 months. Note when you can resume normal foods and activities. Record any unusual abdominal symptoms that might indicate recurrence.
- Users should log their pain levels immediately after treatment and daily for the first week. Set reminders to track when they resume eating solid foods. Create a symptom diary noting any abdominal discomfort, bloating, or pain that might suggest appendix problems are returning.
- Establish a long-term tracking system that flags any return of appendix-related symptoms. Set monthly check-in reminders for the first year after treatment. Create alerts if pain scores increase or new symptoms develop, prompting users to contact their doctor. Track medication use and dietary tolerance over time.
This article summarizes research comparing two medical treatments for appendicitis. It is not medical advice. If you have symptoms of appendicitis (severe abdominal pain, fever, nausea), seek immediate medical attention. Treatment decisions should be made with your doctor based on your individual health situation, local medical expertise, and available resources. The effectiveness and safety of these procedures may vary based on patient factors, provider experience, and healthcare settings. Always consult qualified healthcare professionals before making treatment decisions.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.